EUVIMEDEUVIMED entdecken
Open Access

Structure-guided discovery of ancestral CRISPR-Cas13 ribonucleases

Peter H Yoon iD, Zeyuan Zhang iD, Kenneth J Loi iD, Benjamin A Adler iD, Arushi Lahiri iD, Kamakshi Vohra, Honglue Shi iD, Daniel Bellieny Rabelo iD, Marena Trinidad, Ron S Boger, Muntathar J Al-Shimary iD, Jennifer A Doudna iD

Science · 02.08.2024 · 385 (6708) · 538-543

DOI: 10.1126/science.adq0553 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 02.08.2024. Verfasst von Peter H Yoon und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA. Hauptthemen laut MEDLINE: CRISPR-Associated Proteins, CRISPR-Cas Systems, Evolution, Molecular, Ribonucleases. Die Arbeit wurde bisher 70-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Howard Hughes Medical Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The RNA-guided ribonuclease CRISPR-Cas13 enables adaptive immunity in bacteria and programmable RNA manipulation in heterologous systems. Cas13s share limited sequence similarity, hindering discovery of related or ancestral systems. To address this, we developed an automated structural-search pipeline to identify an ancestral clade of Cas13 (Cas13an) and further trace Cas13 origins to defense-associated ribonucleases. Despite being one-third the size of other Cas13s, Cas13an mediates robust programmable RNA depletion and defense against diverse bacteriophages. However, unlike its larger counterparts, Cas13an uses a single active site for both CRISPR RNA processing and RNA-guided cleavage, revealing that the ancestral nuclease domain has two modes of activity. Discovery of Cas13an deepens our understanding of CRISPR-Cas evolution and expands opportunities for precision RNA editing, showcasing the promise of structure-guided genome mining.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CRISPR-Associated ProteinsCRISPR-Cas SystemsEvolution, MolecularRibonucleasesRNA EditingRNA, Guide, CRISPR-Cas SystemsBacteriophagesCatalytic DomainPhylogeny

Substanzen

CRISPR-Associated ProteinsRibonucleasesRNA, Guide, CRISPR-Cas Systems

Autor:innen und Institutionen

  • Department of Molecular and Cell Biology, University of California, Berkeley, Berkeley, CA, USA.
  • Innovative Genomics Institute, University of California, Berkeley, Berkeley, CA, USA.
  • Howard Hughes Medical Institute, University of California, Berkeley, Berkeley CA, USA.
  • Biophysics Graduate Group, University of California, Berkeley, Berkeley, CA, USA.
  • California Institute for Quantitative Biosciences, University of California, Berkeley, Berkeley, CA, USA.
  • Gladstone Institutes, San Francisco, CA, USA.

ORCID-Profile: Peter H Yoon, Zeyuan Zhang, Kenneth J Loi, Benjamin A Adler, Arushi Lahiri, Honglue Shi, Daniel Bellieny Rabelo, Muntathar J Al-Shimary, Jennifer A Doudna

Förderung

  • Howard Hughes Medical Institute

Zitieren

APA

Yoon, P. H., Zhang, Z., Loi, K. J., Adler, B. A., Lahiri, A., Vohra, K., Shi, H., Rabelo, D. B., Trinidad, M., Boger, R. S., Al-Shimary, M. J., & Doudna, J. A. (2024). Structure-guided discovery of ancestral CRISPR-Cas13 ribonucleases. Science, 385(6708), 538-543. https://doi.org/10.1126/science.adq0553

Vancouver

Yoon PH, Zhang Z, Loi KJ, Adler BA, Lahiri A, Vohra K, et al. Structure-guided discovery of ancestral CRISPR-Cas13 ribonucleases. Science. 2024;385(6708):538-543. doi:10.1126/science.adq0553

BibTeX
@article{Yoon2024,
  author = {Yoon, Peter H and Zhang, Zeyuan and Loi, Kenneth J and Adler, Benjamin A and Lahiri, Arushi and Vohra, Kamakshi and Shi, Honglue and Rabelo, Daniel Bellieny and Trinidad, Marena and Boger, Ron S and Al-Shimary, Muntathar J and Doudna, Jennifer A},
  title = {Structure-guided discovery of ancestral CRISPR-Cas13 ribonucleases},
  journal = {Science},
  year = {2024},
  volume = {385},
  number = {6708},
  pages = {538--543},
  doi = {10.1126/science.adq0553}
}
Kostenlos starten →